临床药师对1例限制性心肌病的用药分析  

Pharmaceutical Care for One Case of Restrictive Cardiomyopathy by Clinical Pharmacist

作　　者：蓝晓红 周永刚 邹颖[2] 李新立[3] 

机构地区：[1]解放军第八一医院药学科,南京210002 [2]江苏省人民医院药剂科,南京210029 [3]江苏省人民医院心内科,南京2100029

出　　处：《药学与临床研究》2014年第2期177-179,共3页Pharmaceutical and Clinical Research

摘　　要：通过临床药师参与心内科1例限制性心肌病的药物治疗:针对重度水肿合并低钠、低钾、低蛋白,选用利尿剂托伐普坦。针对患者白蛋白低,改用白蛋白结合率低的普伐他汀替代阿托伐他汀(蛋白结合率>98%),降低药物的肝肾毒性。Clinical pharmacists implementing pharmaceutical care in drug treatment of a patient with restrictive cardiomyopathy combined right heart failure,severe edema,hyponatremia,hypokalemia,hypoproteinemia is reviewed in this article.Instead of furosemide,tolvaptan was recommended for its little effect on serum potassium and better security role on serum sodium.Potassium-sparing drugs should not be reused.Besides,atorvastatin was replaced with pravastatin which has lower albumin binding rate to reduce the toxicity of liver and kidney.

关 键 词：临床药师 限制性心肌病 利尿剂 阿托伐他汀 

分 类 号：R969.3[医药卫生—药理学]